JENNISON ASSOCIATES LLC 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-06 10:31 am Purchase | 2024-03-06 | 13G | Arcutis Biotherapeutics, Inc. ARQT | JENNISON ASSOCIATES LLC | 12,128,533 10.800% | 3,062,451 (+33.78%) | Filing |
| 2024-02-08 12:52 pm Purchase | 2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | JENNISON ASSOCIATES LLC | 9,066,082 9.600% | 9,066,082 (New Position) | Filing |